BackImmix Biopharma Overview

Immix Biopharma Current Cash

Track Immix Biopharma's current cash ($79M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$79.25M
↑ 397.77% YoYΔ $63.33M vs prior year quarter

Peer average

Loading

Immix Biopharma Current Cash History

Loading

Immix Biopharma vs. peers: Current Cash Comparison

Loading

Immix Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immix Biopharma (IMMX) FAQ

Immix Biopharma posts a current cash of $79M as of March 2026. That compares with $16M in the prior-year period — up 397.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Immix Biopharma's current cash was $16M. The latest reading is $79M — a 397.8% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Immix Biopharma's financial statement story. At $79M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IMMX's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Immix Biopharma's other metric pages and overview cover the third.